TAK1 signaling is a potential therapeutic target for pathological angiogenesis.

Saved in:
Bibliographic Details
Title: TAK1 signaling is a potential therapeutic target for pathological angiogenesis.
Authors: Zhu L; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia.; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Lama S; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia., Tu L; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Dusting GJ; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, VIC, Australia., Wang JH; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia., Liu GS; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia. rickliu0817@gmail.com.; Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, VIC, Australia. rickliu0817@gmail.com.; Aier Eye Institute, Changsha, Hunan, China. rickliu0817@gmail.com.
Source: Angiogenesis [Angiogenesis] 2021 Aug; Vol. 24 (3), pp. 453-470. Date of Electronic Publication: 2021 May 10.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 9814575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7209 (Electronic) Linking ISSN: 09696970 NLM ISO Abbreviation: Angiogenesis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7209
DOI:10.1007/s10456-021-09787-5